Unnamed stage
$10.6m
BiomeBank to scale up with $10.65 million capital raise
Biotech firm BiomeBank raised $10.65 million from Ellerston Capital, the South Australian Venture Capital Fund and The Hospital Research Foundation to expand manufacturing and advance its microbiome therapies.
Also SmartCompany·Techboard